The Midwifery Unit Network (E-MUNet), which is the spinoff of City, University London (CITY UL), aims to support and promote the development and growth of midwifery units (birth centres) throughout Europe so they become the main care pathway for women with an uncomplicated pregnancy, proving holistic care to them and their family. To make midwifery units an easily accessible, mainstream option for women with uncomplicated pregnancies and their partners, through research, policy, leadership, quality improvement, training, influencing, information, support and networking activities. Recent studies have shown that midwifery-led units provide a better option for healthy women without any pregnancy complications, as the outcomes are similar to consultant-led obstetric units in hospitals while also resulting in fewer interventions and lower morbidity for mothers. This evidence is now reflected in the NICE national guidelines for care at birth.
Behavioural Fusion is an innovative company specialising in the application of rigorous and relevant behavioural economics to solve real-world business problems. Formed by academics and graduates from City, University of London (CITY UL) with specialisms in psychology, business, economics, and neuroscience, and underpinned by industry experts, they apply rigorous and credible solutions that make a real impact. The company is not only informed by the behavioural scientific literature, but they also contribute to it by publishing original research reports, papers and books. Their mission is to create behavioural economic solutions that work - incisive human insight impacting the bottom line - assured by academic rigour, professional integrity, and client focus. They construct creative synergy - partnering with sector experts - to offer the breadth and depth of specialist knowledge and experience needed for service excellence.
Scientists at the The University of Queensland and the University of California San Francisco have found a new way to inhibit the growth of the bacterium that causes tuberculosis (lat. Phthisis). UQ School of Chemistry and Molecular Biosciences Deputy Head Professor James De Voss said the discovery held promise for the development of treatments. The research team, led by Professor Paul Ortiz de Montellano in the US, investigated the impact of compounds related to cholesterol on the tuberculosis-causing bacterium Mycobacterium tuberculosis. Cholesterol is known to affect the virulence and infectivity of TB.
Researchers at the University of Rochester Medical Center (URMC) have discovered a potentially new approach to deliver therapeutics more effectively to the brain. The research could have implications for the treatment of a wide range of diseases, including Alzheimer’s, Parkinson’s, ALS, and brain cancer. According to Maiken Nedergaard M.D., D.M.Sc., co-director of the University of Rochester Medical Center (URMC) Center for Translational Neuromedicine and lead author of the article, improving the delivery of drugs to the central nervous system (lat. Systematis nervosi centralis) is a considerable clinical challenge. The findings of this study demonstrate that the brain’s waste removal system could be harnessed to transport drugs quickly and efficiently into the brain.
The eNose Company, which was founded in 2013, focus on disease screening using exhaled-breath analysis. For this purpose, a dedicated point-of-care electronic nose was developed (Aeonose). After finishing a number of pilot studies in oncology, infectious-, and neurological diseases, The eNose Company currently focuses on colon cancer (lat. Carcinoma), lung cancer, tuberculosis (lat. Phthisis), and fasting. It develops diagnostic tools for screening of diseases through exhaled breath in order to ease patients’ lives, provide physicians with additional diagnostic tools, and lower the burden of the healthcare community. In 2014, the Aeonose received a CE-mark, and in 2015 the company was ISO 13485 certified.
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system, in which the body's own immune cells attack the fatty, insulating myelin sheath surrounding nerve fibers. The regeneration of intact myelin sheaths is a necessary prerequisite for patients to recover from MS relapses. Nevertheless, the body's ability to regenerate myelin decreases with age. A team led by Prof. Mikael Simons from the Technical University of Munich (TUM) has now found a possible explanation. Fat derived from myelin, which is not carried away rapidly enough by phagocytes, can trigger chronic inflammation that, in turn, impedes regeneration. Furthermore, in a second publication, Simons' team describes the discovery of novel cell type, which appears only when a myelin sheath is being created. The myelin sheath plays a decisive role in the function of the central nervous system. It is a specialized membrane enriched in lipids, which insulates nerve fibers so that electrical signals can be passed on quickly and efficiently.